Dendritic Cell Generation
Dendritic Cell Generation - Related Videos
02:57
Bone Marrow-Derived Dendritic Cells Generation: A Method to Generate Dendritic Cells from Mouse Bone Marrow
0 Views •
2023
This video describes a protocol for the generation of dendritic cells--key antigen-presenting cells that activate T cells--from the bone marrow of an adult mouse.
03:47
Generation of Immature, Mature, and Tolerogenic Dendritic Cells from Monocytes
0 Views •
2025
This video demonstrates the generation of immature, mature, and tolerogenic dendritic cells, or DCs, from human monocytes. The incubation of monocytes with growth factors and cytokines leads to the production of immature DCs. In response to immune regulatory molecules, immature DCs differentiate into tolerogenic and mature DCs.
06:09
Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
0 Views •
Cited by 37 •
2016
Immature dendritic cells can be selectively differentiated into tolerogenic or mature dendritic cells to regulate the balance between immunity and tolerance. This work presents a means to generate from immature monocyte derived dendritic cells (moDCs), in vitro tolerogenic and mature moDCs that differ in metabolic phenotypes.
04:39
In Vitro Generation of Plasmacytoid Dendritic Cells from Common Lymphoid Progenitors
0 Views •
2025
This video demonstrates an in vitro assay to generate plasmacytoid dendritic cells (pDCs) from common lymphoid progenitor cells (CLPs). Upon co-culturing purified CLPs with γ-irradiated feeder cells in the presence of Fms-like tyrosine kinase-3 ligand (FL), the CLPs differentiate into non-adherent pDCs, the presence of which is confirmed using flow cytometry.
12:43
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
0 Views •
Cited by 15 •
2014
Evaluated in syngeneic immunocompetent hosts, cancer stem cell (CSC) based dendritic cell (DC) vaccine demonstrated significantly higher antitumor immunity than traditional DC vaccines pulsed with heterogeneous bulk tumor cells.
FAQs
The cytokine environment guides hematopoietic progenitors or blood monocytes toward a dendritic-cell state. Granulocyte-macrophage colony-stimulating factor and interleukin-4 are key culture signals identified for this purpose. Their inclusion establishes conditions in which the starting cells can differentiate before later exposure to microbial or inflammatory stimuli, allowing investigators to examine subsequent activation and antigen-presenting behavior.
These sources provide alternative cellular inputs for generating dendritic cells in laboratory systems. Hematopoietic progenitors represent an early blood-cell population, whereas blood monocytes are already circulating immune cells. Using either source allows researchers to investigate differentiation under defined cytokine conditions and select a starting material suited to studies of infection, immune regulation, or antigen presentation.
Microbial or inflammatory signals promote maturation after the initial culture and differentiation phase. This maturation is associated with increased major histocompatibility complex expression and stronger costimulatory activity, two features relevant to communication with T cells. Comparing cells before and after stimulation therefore helps researchers examine how danger-associated signals alter their capacity to initiate adaptive immune responses.
Maturation links antigen handling with more effective immune-cell communication. Generated dendritic cells can be examined for antigen uptake and processing, while increased major histocompatibility complex expression supports antigen display and enhanced costimulatory activity supports interaction with T cells. These coordinated changes make the system useful for studying how innate sensing influences the development of adaptive immune responses during infection.
A typical workflow begins by selecting hematopoietic progenitors or blood monocytes and culturing them with cytokines such as granulocyte-macrophage colony-stimulating factor and interleukin-4. After differentiation, the cells are exposed to microbial or inflammatory signals to promote maturation. Researchers can then assess antigen uptake, processing, major histocompatibility complex expression, costimulatory activity, or T-cell activation.
The system is useful when investigators need to connect microbial sensing with downstream adaptive immunity. Generated cells provide an experimental setting for examining how infection-related signals influence maturation, antigen uptake, processing, and T-cell activation. This supports host-pathogen studies by separating cellular differentiation from later stimulation and enabling comparison of immune responses under defined laboratory conditions.
Generated dendritic cells provide a controllable platform for examining antigen presentation and T-cell activation across several research areas. In vaccine studies, they can help investigate immune stimulation; in cancer immunotherapy, they support analysis of antigen-driven responses; and in immune-regulation research, they allow examination of how maturation and costimulatory activity shape adaptive immune interactions.